Your shopping cart is currently empty

Troleandomycin (Triacetyloleandomycin), a macrolide antibiotic, is an orally active and specific CYP3A inhibitor that induces mnemonic speech, induces prolonged cholestasis, and can be used in the study of asthma.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $499 | - | In Stock | |
| 2 mg | $599 | - | In Stock |
| Description | Troleandomycin (Triacetyloleandomycin), a macrolide antibiotic, is an orally active and specific CYP3A inhibitor that induces mnemonic speech, induces prolonged cholestasis, and can be used in the study of asthma. |
| In vitro | Troleandomycin significantly inhibits microsomal side chain hydroxylation in mouse and human livers in a dose-dependent manner. [1] |
| In vivo | Troleandomycin significantly inhibits the 6β-hydroxylation of testosterone, the 25- and 26-hydroxylation of 5β-cholestane-3α, 7α, and 12α-triol, and the 23R-, 24R-, 24R-, 5β-cholestane-3α, 7α 24S- and 27-hydroxylation, 12α, 25-tetrol in recombinant CYP3A4 and microsomes, but the IC50 value of microsomes is slightly higher than that of recombinant CYP3A4.[2] |
| Synonyms | Triacetyloleandomycin, Micotil, Matromycin T, Cyclamycin, Aovine, AI3-50166 |
| Molecular Weight | 813.97 |
| Formula | C41H67NO15 |
| Cas No. | 2751-09-9 |
| Smiles | [H][C@@]1(C[C@H](OC)[C@@H](OC(C)=O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2OC(C)=O)N(C)C)[C@@H](C)C[C@@]2(CO2)C(=O)[C@H](C)[C@@]([H])(OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]1C |
| Relative Density. | 1.31g/cm3 |
| Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (61.43 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (2.46 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.